EGFR and neoplasm: EGFR-mediated tumor progression and resistance to EGFR TKIs were found to be linked to ROS-induced oxidative stress, stemming from mitochondrial dysfunction, NADPH oxidase (NOX) overactivation, and the aberrant expression of antioxidant enzymes [28,29].